Search

everythinglearnresearchcommunity

for

Search:↓

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Imuvert can prevent some chemotherapy-induced hair loss.

MK-5108 is safe and shows potential against tumors, especially alone.

The multimodal microemulsion with minoxidil, diclofenac, and tea tree oil is more effective for hair growth than minoxidil alone.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

Microinfusion of methotrexate can help treat frontal fibrosing alopecia.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

The method effectively showed that the two exemestane preparations are bioequivalent.

A new lipid-based formula using myristyl myristate can improve estradiol treatment for hair loss.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Microneedling and oral tranexamic acid both improve facial melasma, but microneedling shows more sustained benefits.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

A reliable method was developed to measure Minoxidil and Tofacitinib in gel for hair loss treatment.

5% ET-02 is a more effective and safe treatment for hair loss than current options.

Minoxidil showed better improvement than methotrexate in treating localized alopecia areata.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Medroxyprogesterone acetate iontophoresis safely and effectively reduces facial hair growth in women.